Voyager Therapeutics Inc

NASDAQ:VYGR   4:00:00 PM EDT
9.31
-0.25 (-2.62%)
5:36:30 PM EDT: $9.36 +0.05 (+0.54%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)505.51M
Current PE3.82
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.48 Million
Adjusted EPS-$0.44
See more estimates
10-Day MA$9.46
50-Day MA$8.37
200-Day MA$8.54
See more pivots

Voyager Therapeutics Inc Stock, NASDAQ:VYGR

75 Hayden Avenue, Lexington, Massachusetts 02421
United States of America
Phone: +1.857.259.5340
Number of Employees: 162

Description

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.